Neuro-visceral immunometabolic network phenotyping via baseline whole-body [¹⁸F]FDG PET/CT underlying pathologic response to neoadjuvant immunochemotherapy in resectable NSCLC.
APA
Shi C, Xue S, et al. (2026). Neuro-visceral immunometabolic network phenotyping via baseline whole-body [¹⁸F]FDG PET/CT underlying pathologic response to neoadjuvant immunochemotherapy in resectable NSCLC.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-07866-7
MLA
Shi C, et al.. "Neuro-visceral immunometabolic network phenotyping via baseline whole-body [¹⁸F]FDG PET/CT underlying pathologic response to neoadjuvant immunochemotherapy in resectable NSCLC.." European journal of nuclear medicine and molecular imaging, 2026.
PMID
41885941
같은 제1저자의 인용 많은 논문 (5)
- Oridonin-loaded liposomes targeting lung cancer: formulation and delivery and .
- Less is more: once vs. multiple radioactive iodine (RAI) therapy in patients with RAI-avid pulmonary micrometastatic differentiated thyroid cancer.
- Comprehensive discovery and functional characterization of the noncanonical proteome.
- Blood metal levels predict digestive tract cancer risk using machine learning in a U.S. cohort.
- The Solute Carrier Family 47 Member 1, Transcriptionally Regulated by GATA Binding Protein 6, Inhibits Ferroptosis in Gastric Cancer.